Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' Oncodesign Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Oncodesign since January 2007.
Scope:
– Provides intelligence on Oncodesign's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Oncodesign and its subsidiaries since 2007. – Information about key financial and legal advisors for Oncodesign's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes Oncodesign's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Oncodesign. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Oncodesign’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The Asia Pacific dermatology treatment devices market is expected to reach US$ 1,680.81 million in 2027 from US$ 962.14 million in 2019; it is estimated to grow with a CAGR of 7.4% from 2020 to 2027. The growth of this market is attributed to the key driving factors such as rising awareness regarding skin diseases and increasing demand...
Blepharitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Blepharitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides top line data relating to the clinical...
Global Hospital Care Partnering 2014 to 2020 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital...
Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the...
The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies...
Colitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Colitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Colitis Clinical trials scenario.This report provides top line data relating to the clinical trials on Colitis. Report...
The global dermatology treatment devices market is expected to reach US$ 8,800.07 million in by 2027 from US$ 5,320.73 million in 2019;. The market it is estimated to grow with at a CAGR of 6.7% from 2020- to 2027. Factors such as rising prevalence of skin issues and technological advancements in dermatology treatment devices drive...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.